Merck & Co., Inc. (NYSE:MRK) wants to acquire Idenix for the Hepatitis C treatment it is developing, specifically, IDX21437, which Merck wants to use in combination with its own Hepatitis C pipeline.
Merck & Co., Inc. (NYSE:MRK) net profit margin is 14.00% and weekly performance is 1.17%. On last trading day company shares ended up $58.92. Analysts mean target price for the company is $59.44. Merck & Co., Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 3.75%.
TherapeuticsMD Inc. (NASDAQ:TXMD)‘s stock had its “positive” rating reaffirmed by equities researchers at Noble Financial in a research note issued on Wednesday. TherapeuticsMD Inc. (NYSEMKT:TXMD) shares advanced 6.35% in last trading session and ended the day on $5.36. TXMD gross Margin is 76.20% and its return on assets is -66.40%.TherapeuticsMD Inc. (NYSEMKT:TXMD) quarterly performance is -26.88%.
GlaxoSmithKline plc (ADR) (NYSE:GSK) Consumer Nigeria Plc has notified the Nigerian Stock Exchange that it’s board has appointed Mr. Dayanand Thandalam Sriram as the Managing Director of the Company. GlaxoSmithKline plc (ADR) (NYSE:GSK) shares moved up 0.20% in last trading session and was closed at $54.54, while trading in range of $54.39 – $54.71. GlaxoSmithKline plc (ADR) (NYSE:GSK) year to date (YTD) performance is 4.72%.
On 20 June, AstraZeneca plc (ADR) (NYSE:AZN) said its board had secured a green signal from shareholders for delisting after deferring twice in the past. The company had deferred the delisting plan due to an expected high-stakes deal between the parent company AstraZeneca Plc and Pfizer Inc., where the latter was looking to buy out the entire company in a deal valued at about $120 billion. AstraZeneca plc (ADR) (NYSE:AZN) ended the last trading day at $75.47. Company weekly volatility is calculated as 0.92% and price to cash ratio as 18.65.AstraZeneca plc (ADR) (NYSE:AZN) showed a positive weekly performance of 1.66%.
Novartis AG (ADR) (NYSE:NVS) offices in Italy were searched by authorities seeking information on the pricing of two influenza vaccines, adding to the Swiss drugmaker’s woes in the country. Novartis AG (ADR) (NYSE:NVS) net profit margin is 16.50% and weekly performance is 1.84%. On last trading day company shares ended up $90.98. Analysts mean target price for the company is $92.11. Novartis AG (ADR) (NYSE:NVS) distance from 50-day simple moving average (SMA50) is 3.49%.